Health conditions and medications in people with HIV in the Basque Country
Part of Immune system & allergy, Infections clinical trials.
This study looks at people living with HIV who also have other health conditions or take multiple medications, compared to the general population in the Basque Country. By joining, you help researchers understand how to better care for people with HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are living with HIV.
- You receive your HIV care at one of these hospitals: Araba, Cruces, Basurto, Donostia, or Galdakao-Usansolo in the Basque Country.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain immune cells (NK cells) behave in people who have been on HIV treatment for a long time. It aims to understand why some people's immune systems respond differently, which could help improve future treatments.
This study is tracking the long-term health of people living with HIV who receive care at a specific hospital clinic. It aims to better understand HIV over time.
This is an observational study that follows people to better understand how HIV and other infections (like sexually transmitted infections) happen and change over time. It may help researchers improve prevention and care, but it is mainly for monitoring rather than testing a new treatment.
This study follows people living with HIV who also have hepatitis C antibodies, to better understand how HIV and hepatitis C affect health over time. You may be able to join if you meet the age and enrollment requirements, even if your hepatitis C virus level is currently undetectable.
This study focuses on HIV in a research “platform” run by a university. It may help researchers learn more about HIV and improve care over time.
This study looks back at people with HIV to understand how often and why heart problems happen. It may help doctors better track heart risk and complications over time.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.